Meanwhile, we used both the non-selective P1R and P2R antagonists as well as the specific antagonists available against A1R, P2X7R, and P2Y6R to identify the putative PRs that accounts for endothelial dysfunction in T2D. The gene discussed is WNK3; the disease is endothelial dysfunction.